Author:
Carter Charles A.,Wojciechowski Norbert J.,Hayes J. Michael,Skoutakis Vasilios A.,Rickman Lucy A.
Abstract
Terfenadine is an antihistamine recently approved for use in the U.S. Terfenadine possesses a unique chemical structure when compared with other antihistamines. It is a selective inhibitor of H1-receptors with little or no anticholinergic, antiserotoninergic, or antiadrenergic effects. Comparative studies have shown that terfenadine is as effective as other antihistamines in the treatment of allergic rhinitis and other hypersensitivity conditions. This drug produces a minimal amount of central nervous system (CNS) depression, which is documented by studies demonstrating that terfenadine and its metabolites do not readily pass into the CNS and have little affinity for central H1-receptors. The lack of CNS depression and anticholinergic effects, and the long duration of action that allows twice-a-day dosing make terfenadine an attractive alternative to other antihistamines.
Subject
Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics
Reference28 articles.
1. AMA drug evaluations. Chicago, IL: American Medical Association, 1983: 1465–79.
2. Terfenadine A Review of its Pharmacodynamic Properties and Therapeutic Efficacy
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献